0000950170-24-046918 Sample Contracts

ARCA BIOPHARMA, INC. SECOND AMENDMENT TO RETENTION BONUS LETTER

Retention Bonus Letter • April 23rd, 2024 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado

• Contract Type
  Retention Bonus Letter
• Filed
  April 23rd, 2024
• Company
  ARCA Biopharma, Inc.
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Colorado

This second amendment (this “Amendment”) is entered into effective as of April 22, 2024 by and between Thomas A. Keuer (“Executive”) and ARCA biopharma, Inc. (the “Company,” and together with Executive, the “Parties”).